Dicerna Pharmaceuticals
DRNA
#4185
Rank
S$3.84 B
Marketcap
S$49.32
Share price
0.00%
Change (1 day)
17,276.09%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: S$3.84 Billion

As of June 2026 Dicerna Pharmaceuticals has a market cap of S$3.84 Billion. This makes Dicerna Pharmaceuticals the world's 4185th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022S$3.99 B-0.84%
2021S$4.02 B82.33%
2020S$2.20 B3.86%
2019S$2.12 B113.39%
2018S$0.99 B59.72%
2017S$0.62 B621.03%
2016S$86.5 M-74.98%
2015S$0.34 B-10.67%
2014S$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$185.39 B 4,725.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$235.09 B 6,019.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$362.88 B 9,344.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$0.72 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$47.90 B 1,146.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$14.87 B 287.04%๐Ÿ‡บ๐Ÿ‡ธ USA